Advertisement

Topics

Cowen Inc. Company Profile

03:59 EDT 23rd October 2018 | BioPortfolio

Cowen Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales and trading, prime brokerage, global clearing and commission management through its two business segments: Cowen Investment Management and its affiliates make up the Company’s alternative investment segment, while Cowen and Company, a member of FINRA and SIPC, and its affiliates make up the Company’s broker-dealer segment. Cowen Investment Management provides alternative asset management solutions to a global client base and manages a significant portion of Cowen’s proprietary capital. Cowen and Company and its affiliates offer industry focused investment banking for growth-oriented companies, domain knowledge-driven research, a sales and trading platform for institutional investors and a comprehensive suite of prime brokerage services. Founded in 1918, the firm is headquartered in New York and has offices worldwide. For additional information, visit www.cowen.com.


News Articles [53 Associated News Articles listed on BioPortfolio]

Cardinal Health (CAH) Upgraded to Buy by Cowen

The firm currently has a $74.00 price objective on the stock. Cowen's target price points to a potential upside of 18.61% from the stock's previous close.

George Millstien, Managing Director, Cowen

In this episode of PharmaTelevision News Review, filmed at AusBio 2012 in Melbourne, Australia, Fintan Walton talks to George Millstien, Managing Director at Cowen

Incyte-Aktie hat Unterstützung!

New York - Incyte-Aktienanalyse des Analysten Eric Schmidt von Cowen and Company: Aktienanalyst Eric Schmidt von Cowen and Company rechnet laut einer Aktienanalyse in Bezug auf die Aktien des US-bi...

Cowen Research Report: Ignore Equity Analysts in Terms of Biotech Stocks

Cowen Research’s biotech team published a recent report and concluded that investors would have better luck ignoring—or even doing the complete opposite—of what equity analysts advise.

Vertex Pharmaceuticals-Aktie: Konkurrenz hat das Nachsehen!

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Analyst Phil Nadeau von Cowen and Company: Phil Nadeau, Aktienanalyst von Cowen and Company, rechnet laut einer Aktienanalys...

Advanced Micro Devices sollte von Intel-Problemen profuitieren!

New York (www.aktiencheck.de) - Advanced Micro Devices-Aktienanalyse des Analysten Matthew Ramsay von Cowen and Company: Laut einer Aktienanalyse äußert Matthew Ramsay, Analyst von Cowen and Compan....

General Electric-Aktie könnte weiter unter Druck stehen!

New York - General Electric-Aktienanalyse von Analyst Gautam Khanna von Cowen and Company: Laut einer aktuellen Aktienanalyse erwartet Analyst Gautam Khanna von Cowen and Company im Hinblick auf di...

Therachon closes $60mm mezzanine financing

Rare disease-focused Therachon AG raised $60mm in a mezzanine financing led by Novo Holdings, which was joined by other new backers Cowen Healthcare Investments, Pfizer Ventures, and Tekla Capital Man...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [7 Associated Companies listed on BioPortfolio]

Cowen Inc.

Cowen Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, sales an...

Cowen Group Inc.

Cowen Group, Inc. is a diversified financial services firm and, together with its consolidated subsidiaries, provides alternative asset management, investment banking, research, a...

Cowen Group, Inc.

Cowen Group, Inc. is a leading diversified financial services firm providing alternative investment management, investment banking, research, and sales and trading services through its business units,...

Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners is a global healthcare private equity firm that invests principally in commercial-stage biopharmaceutical and medical device companies and products, through the purch...

Cowen and Company

Cowen and Company's success and growth during the past decade of tumultuous consolidation and change in investment banking is a result of the power of our focus. The company’s foundation of unsurpas...

More Information about "Cowen Inc." on BioPortfolio

We have published hundreds of Cowen Inc. news stories on BioPortfolio along with dozens of Cowen Inc. Clinical Trials and PubMed Articles about Cowen Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cowen Inc. Companies in our database. You can also find out about relevant Cowen Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record